Most patients with RCC have a deletion of chromosome 3p and genomic alterations in the Von Hippel–Lindau (VHL) tumor suppressor allele, accompanied by the subsequent loss of other tumor suppressor genes, including PBRM1, SETD2, BAP1, and/or KDM5C. Here, SETD2 is linked to neoplasm.